Available for over a year

Are ADHD-like symptoms during perimenopause just down to hormonal changes or could they actually be revealing undiagnosed ADHD? Brain fog can be a key symptom of both, which means it’s not always easy to tell the difference, leaving women unsure. ‘Scummy Mummies’ podcaster Helen Thorn shares her experience, while Claudia Hammond unpicks the evidence with Dr Jessica Agnew-Blais. And Kerry explains the impact of getting an ADHD diagnosis in adulthood.

And Catherine Loveday, Professor of Cognitive Neuroscience at the University of Westminster, discusses the difficulties of accurate cognitive tests to measure brain fog.

Plus, brand-new research on a different way to teach mental health classes in schools. Previously, All in the Mind revealed that evidence for teaching universal strategies was often disappointing. Now Professor Tim Dalgleish at the University of Cambridge has results of a new approach called One Step Back.

And finally, for anyone who runs or goes to the gym, there’s a new study of what’s happening in the body when exercising to our favourite music.

Presenter: Claudia Hammond
Producer: Erika Wright
Editor: Ilan Goodman
Production coordinator: Jana Bennett-Holesworth
Sound engineer: Neva Missirian

Programme Website



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Explore More

Columbia scientists may have found a universal antiviral

For a few dozen people in the world, the downside of living with a rare immune condition comes with a surprising superpower — the ability to fight off all viruses.

US health care is rife with high costs and deep inequities, and that’s no accident – a public health historian explains how the system was shaped to serve profit and politicians

A few years ago, a student in my history of public health course asked why her mother couldn’t afford insulin without insurance, despite having a full-time job. I told her

Higher buprenorphine doses help patients stay in opioid use disorder treatment, new study finds

Patients who are prescribed higher daily doses of the medication buprenorphine for opioid use disorder are significantly more likely to stay in treatment. Those on 17 to 24 milligrams averaged